Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00848991 · ClinicalTrials.gov registry record · Phase 3
Comparison of Propofol to Precedex With Propofol for Emergence and Recovery in Patients Having Craniotomy Surgery
A Phase 3 study, sponsored by The Cooper Health System.
- Completed
- Registry status
- Phase 3
- Development phase
- 15
- Enrollment target
NCT00848991 is a Phase 3 study that has completed, run by The Cooper Health System. The registered enrollment target is 15 participants.
The verdict
NCT00848991, a Phase 3 study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 15 participants
- Enrollment target
Study Summary
Primary Hypothesis: The use of a Precedex infusion, in addition to propofol during surgery, will improve patient management through the anesthesia postoperative recovery period determined by improvement in patients? tolerance of the endotracheal tube. Secondary hypothesis: The use of a Precedex infusion, in addition to propofol during surgery will provide improved hemodynamic stability.
Interventions
- DRUG Propofol
- DRUG Precedex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00848991
The ClinicalTrials.gov registry entry for NCT00848991 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Propofol is the first listed.
NCT00848991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00848991 about?
NCT00848991 is a clinical study titled "Comparison of Propofol to Precedex With Propofol for Emergence and Recovery in Patients Having Craniotomy Surgery". Primary Hypothesis: The use of a Precedex infusion, in addition to propofol during surgery, will improve patient management through the anesthesia postoperative recovery period determined by improvement in patients? tolerance of the endotracheal tube. Secondary hypothesis: The use of a Precedex inf...
What is the current status of trial NCT00848991?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 15 participants. The study started on 2009-02. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00848991?
The interventions under investigation include: Propofol (DRUG), Precedex (DRUG).
Who is sponsoring clinical trial NCT00848991?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.